1.	Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PT-SM-1-Op-Cancer, NCT00916890
2.	A Study to Evaluate Efficacy and Safety of Targin Compared to OxyContin in Korean Cancer Patients Phase: Phase IV Type: Supportive care Status: Active Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OXN10-KR-002, NCT01313780
3.	A Study to Assess the Efficacy and Safety of TARGIN in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 20 to 79 Sponsor: Pharmaceutical / Industry Protocol IDs: OXN12-KR-402, NCT01675531
4.	Safety of Fentanyl TAIFUN Treatment Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CL_700_014, NCT00822614
5.	A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain Phase: Phase III Type: Supportive care Status: Active Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR017188, JNS024ER-KAJ-C02, NCT01165281
6.	Use of Continuous Wound Infusion of Bupivacaine for Analgesia Following Axillary Clearance Surgery Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: AC-CUH, NCT01314144
7.	Pilot Study of Tumescent Versus Standard Mastectomy in Women With Stage I-III Breast Cancer Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UCD-CCSO001, CCSO001, 200816282-1, NCT00859157